Rheum Now

Directions Website Contact the practice

Rheum Now The rheumatologists' preferred online source for daily and facile access to news, information, pract

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for Rheumatologists and healthcare providers in related fields. Many rheumatic disease and arthritis topics are covered, such as: osteoarthritis, psoriatic arthritis, spondylitis, JRA, JIA, Juvenile arthritis, psoriasis,, psoriatic spondylitis, ankylosing spondylitis, spondyloarthritis, osteoporosis, URAT-1, mosquito, chikungunya, zika, dengue, REMS, synovium, synovitis, Twitter, FBS, instagram, slideshare, microbiome, FDA, Obesity, axial, interchangeability, myositis, DM/PM, 14-3-3, CCP, ACPA, carbamylated, osteopenia, biologics, non-TNF biologics, NSAIDs, TNF inhibitors, Enbrel, Humira, adalimumab, etanercept, Remicade, infliximab, Cimzia, certolizumab, Inflectra, Remseima, Simponi, golimumab, Kineret, anakinra, Ilaris, Arcalyst, pegloticase, Krystexxa, Stelara, Cosentyx, apremilast, Otezla, Actemra, tocilizumab, Orencia, abatacept, Rituxan, rituximab, Xeljanz, tofacitinib, baricitinib, methotrexate, prednisone, allopurinol, colchicine, febuxostat, Uloric, Zurampic, biosimilars, Plaquenil, sulfasalazine, cyclosporin, fibromyalgia, autoimmune disease, gout, lupus, drug safety, RA, rheumatoid arthritis, joint pain, musculoskeletal, biomarker, Woodcock, Cush, Kavanaugh, Cathepsin, guidelines, ILD, interstitial lung disease, week in review, year in review, antimalarial, pregnancy, fertility,drug safety, risk communication, latent TB, tuberculosis, expert, Taltz, Lyme disease, mortality, comorbid, comorbidities, PSS, CREST, systemic sclerosis, scleroderma, morphea, AOSD, Still's disease, Rheumatology, infection, septic arthritis, osteomyelitis, back pain, SPARTAN, polypharmacy, adherence, HAQ, fatigue, hyperuricemia, gout, pseudogout, CPPD, CV risk, cancer, drug safety, registry, early arthritis, generics, TNFi, vaccine, vaccination, herpes zoster, vasculitis, PMR, polymyalgia rheumatica, GCA, GPA, Wegener's, temporal arteritis, EULAR, ACR, APLAR, RWCS, CCR, CDC, Sclerostin, IL-6, IL-1, TNF, IL-23, IFN, interferon, pulmonary hypertension, vitamin D, carpal tunnel syndrome, sleep, sleep apnea, restless legs, hidradenitis supurative, ultrasound, Doppler, lab tests, CRP, ESR, ANA, ANCA, HLA-B27, uric acid, hyperuricemia, case of the week, calcium bisphosphonates, smoking, obesity, crystal, mortality, placebo, EMR, ESR, Forteo, Prolia, Arthritis Advisory Committee, skin cancer, dendritic, PML, mycophenolate, consult, bone marrow, CORRONA, BSRBR, RABBIT, lesinurad, steroid, Sjogren's, JAMA, NEJM, nonadherence, Curbside Consult, digital ulcers opioids, bisphosphonate, fracture, metanalysis, antiphospholipid, anticardiolipin, Calabrese, risk factors, knee, hip, replacement, uricosuric, sarcoid, periodontal, periodontitis, MCP, PIP, CMC1, MTP, Rheumaknowledgy. Please visit rheumnow.com if you are a rheumatologist or other healthcare provider looking to join rheumatologists to discuss arthritis and rheumatic disease symptoms and treatments.

09/29/2026

In the final webinar in this series, we move beyond the medication to explore what comprehensive obesity care can look like in rheumatology practice. Experts will discuss practical approaches to patient conversations, lifestyle support and referrals, overcoming weight bias and barriers to care, and building a sustainable care model that leverages the broader healthcare team, technology, and current clinical guidelines.

09/22/2026

In this webinar, experts discuss the rapidly evolving landscape of obesity treatment, from lifestyle interventions and bariatric surgery to the latest incretin-based therapies and emerging approaches to precision management. Faculty will share practical guidance on selecting appropriate treatments, optimizing GLP-1/GIP therapy, navigating safety, cost and compounding concerns, and providing comprehensive care that considers issues such as sarcopenia and bone health.

09/15/2026

Explore the complex relationship between obesity and inflammation and how excess adiposity can accelerate inflammatory and autoimmune rheumatic disease through metabolic, biomechanical, and immunologic pathways. In this webinar, experts will examine the biology of fat, the impact of obesity on disease risk and treatment response, and how weight loss and other interventions may modify inflammation and improve outcomes.

Speakers:
Dr. Juliana Simonetti
Dr. Lihi Eder
Dr. Naveed Sattar
Dr. Lee Kaplan
Dr. Jack Cush (moderator)

09/08/2026

Join us for Journal Club exploring the TOGETHER PsA and STEP 9 trials and what emerging evidence tells us about the relationship between obesity, weight loss, and rheumatic disease. Authors of the papers and experts will discuss the results of these trials, discuss how we consider obesity as both a comorbidity and part of the disease course, and share practical strategies for addressing obesity in everyday rheumatology practice.

Speakers:
Dr. Philip Mease
Dr. Tom Appleton
Dr. Jack Cush (moderator)

Join us for the first of four webinars this month!This Journal Club will explore the TOGETHER PsA and STEP 9 trials, and...
09/04/2026

Join us for the first of four webinars this month!

This Journal Club will explore the TOGETHER PsA and STEP 9 trials, and what emerging evidence tells us about the complex relationship between obesity, weight loss, and rheumatic disease.

The authors and leading experts will:

• Examine the results and clinical implications of these important trials
• Discuss obesity as both a comorbidity and part of the rheumatic disease course
• Share practical strategies for addressing obesity in everyday rheumatology practice

Speakers:

• Dr. Philip Mease
• Dr. Tom Appleton
• Dr. Jack Cush, moderator

Don’t miss this timely and clinically relevant conversation.

Register Today: https://us02web.zoom.us/webinar/register/WN_NGp7c3cpQX-8lCCmT5QaSw #/registration

"Be so good they can't ignore you." - Steve Martin
08/13/2026

"Be so good they can't ignore you." - Steve Martin

08/13/2026

"The mediocre teacher tells. The good teacher explains. The superior teacher demonstrates. The great teacher inspires" - William Arthur Ward

Systematic review of cardiovascular death in systemic immune-mediated Dz (SIDs): 39 studies,  171,748 pts -  SIDs assoc ...
01/14/2026

Systematic review of cardiovascular death in systemic immune-mediated Dz (SIDs): 39 studies, 171,748 pts - SIDs assoc w/ signif. higher CV mortality (HR 1.26; 1.09-1.47; p = 0.002), especially for RA, SLE, GPA & females. 92% of CV deaths from acute coronary syndrome (ACS)

To perform a systematic review and meta-analysis assessing the association between systemic immune-mediated diseases (SIDs) and cardiovascular death. A systematic search of PubMed, Cochrane Library, and ClinicalTrials.gov was performed from ...

US CDC study of age-standardized mortality rate (ASMR) from 1990-2020, there were 39,496  deaths related to scleroderma ...
07/24/2025

US CDC study of age-standardized mortality rate (ASMR) from 1990-2020, there were 39,496 deaths related to scleroderma (SSc) & and 5,163 from SSc w/ renal failure. Deaths lower in males (22%) than females w/ renal failure (78%). Mortality rate of SSc w? renal failure was relatively low and decreasing.

To describe the number of deaths related to systemic sclerosis (SSc) having renal failure, the changing trend in ASMR, and causes of death using a multi-cause method. Annual death toll and ASMR data from 1999 to 2020 were obtained from the death database of the US CDC. All death certificates in the....

NIH study of MSK disease burden finds research on neck pain as most underfunded (0.83%) followed by LBP (13.9%), OA (35....
01/29/2025

NIH study of MSK disease burden finds research on neck pain as most underfunded (0.83%) followed by LBP (13.9%), OA (35.1%) & RA (66.3%) - NIAMS is low compared to other institutes. In USA, MSK dz affect 1 in 3 people, approximately 127.4 million individuals.

Exacerbated by an aging population, musculoskeletal diseases are a chronic and growing problem in the United States that impose significant health and economic burdens. The objective of this study was to analyze the correlation between the burden of ...

Address

Dallas, TX
75234

Alerts

Be the first to know and let us send you an email when Rheum Now posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Rheum Now:

Shortcuts

Sponsored

Share

Category